शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
MANGALAMNSEMangalam Drugs And Organics Limited· Pharmaceuticals & BiotechnologyHighPositive
Announced Wed, 18 Mar, 2026 · 18:30 IST

Shree Rasbihari trading and Investment private Ltd has submitted to  the Exchange  a copyof Disclosure pursuant to Regulations 31(1) and 31(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 by the Promoter(s) / Promoter Group to the Stock Exchange(s) for release of Pledged shares.

Pledge ReleasedOwnership Changes View source PDFExplain this filing

MANGALAM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.7%Reaction day
₹30.98
prior close
₹30.98
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-2.8%+2.1% vs market
Pharmaceuticals peers, median of 156sector-1.8%+1.1% vs sector

On the reaction day the stock moved 2.1 pts more than Nifty Microcap 250 and 1.1 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-1.5
10m
-0.2
15m
+0.0
30m
+0.3
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.7-2.8+2.1-1.8+1.1
Next day
-1.0-2.0+1.0-0.9-0.0
2d
-5.7-6.5+0.7-4.7-1.0
3d
-5.5-3.8-1.7-3.1-2.4
4d
-3.8-1.5-2.3-1.8-2.0
5d
-8.1-4.3-3.9-4.3-3.8
1w
-8.0-2.8-5.3-3.5-4.5
15d
-2.8+8.2-11.0+7.0-9.8
1m
-5.4+10.1-15.5+6.7-12.1
2m
-3.3+12.4-15.8+9.5-12.9
3m
-2.5+23.5-26.0+13.9-16.5
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 156Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Shree Rasbihari Trading and Investments Private Limited, a promoter entity of Mangalam Drugs and Organics Limited, has released 1,73,000 pledged shares (1.09% of total share capital) that were held as security for debt in favor of M/s Famycare Private Ltd. The promoter entity continues to hold 9,82,563 shares (6.20% of total share capital) in the company. After this release, the promoter entity has no remaining encumbered shares. The disclosure was filed on March 18, 2026, under SEBI Takeover Regulations.

Likely market impact

This is a positive development for shareholders as it eliminates the encumbrance risk on the promoter's stake. Pledge releases generally signal improved financial health of the promoter group or fulfillment of debt obligations, reducing the risk of forced selling of shares in the open market.